Protalix BioTherapeutics’ (PLX) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Protalix BioTherapeutics (NYSE:PLX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC...
NOV (NYSE:NOV) Upgraded at StockNews.com
StockNews.com upgraded shares of NOV (NYSE:NOV – Free Report) from a sell rating to a hold rating in a report published on Tuesday. A number...
New York Community Bancorp (NYSE:NYCB) Downgraded by Wedbush
Wedbush downgraded shares of New York Community Bancorp (NYSE:NYCB – Free Report) from a neutral rating to an underperform rating in a research note issued...
IQVIA (NYSE:IQV) Price Target Lowered to $239.00 at JPMorgan Chase & Co.
IQVIA (NYSE:IQV – Free Report) had its target price reduced by JPMorgan Chase & Co. from $262.00 to $239.00 in a report released on Monday,...
JPMorgan Chase & Co. Lowers Recursion Pharmaceuticals (NASDAQ:RXRX) Price Target to $10.00
Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) had its target price decreased by JPMorgan Chase & Co. from $11.00 to $10.00 in a research note issued...
Occidental Petroleum (NYSE:OXY) PT Lowered to $78.00 at JPMorgan Chase & Co.
Occidental Petroleum (NYSE:OXY – Free Report) had its target price decreased by JPMorgan Chase & Co. from $81.00 to $78.00 in a research report sent...